GLP Watchdog

Direct Meds vs RxSpan MD

Direct Meds has an open FDA warning letter dated September 9, 2025. RxSpan MD has none. On compounded tirzepatide injection, RxSpan MD costs $840 less a year at standing rates: $329 a month against $399 a month at Direct Meds. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Direct Meds / RxSpan MD

Direct Meds logo

Direct Meds

7.1/10

RxSpan MD logo

RxSpan MD

7.9/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded oral semaglutide
$249/moCompounded semaglutide injection
States
48 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Direct Meds
Visit RxSpan MD

Both Direct Meds and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Direct Meds 7.1, RxSpan MD 7.9). How we are paid

What the record shows

  1. 01

    Direct Meds has an open FDA warning letter dated September 9, 2025. RxSpan MD has none.

  2. 02

    RxSpan MD names four pharmacies. Direct Meds names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, RxSpan MD costs $840 less a year at standing rates: $329 a month against $399 a month at Direct Meds. It is one of two products the two sell at comparable terms.

  4. 04

    Only Direct Meds lists a price for compounded oral semaglutide and compounded oral tirzepatide. Only RxSpan MD lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    RxSpan MD covers two states Direct Meds does not.

  6. 06

    Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days; RxSpan MD states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Direct Meds

RxSpan MD

Compounded semaglutide injection

$297/mo

$3,564 a year

$249/moLower

$2,988 a year

Compounded tirzepatide injection

$399/mo

$4,788 a year

$329/moLower

$3,948 a year

Brand-name semaglutide pen
Not sold or not priced

$1,299/mo

$15,588 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,069/mo

$12,828 a year

Compounded oral semaglutide

$249/mo

$2,988 a year

Not sold or not priced
Compounded oral tirzepatide

$299/mo

$3,588 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping, coaching
Cancel any time
No
Yes, stated
Minimum term
90-day supply shipped at once, remaining months billed every 30 days
None
Refunds
No refunds for medication already received; $35 disposal fee on returns
Not stated
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Direct Meds: October 17, 2026. RxSpan MD: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Direct Meds

7.1/10
  • Sells compounded oral semaglutide and compounded oral tirzepatide, which RxSpan MD does not price
  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Minimum commitment before you can cancel
Visit Direct Meds

The case for RxSpan MD

7.9/10
  • No FDA warning letter on record
  • $576 a year less on compounded semaglutide injection
  • $840 a year less on compounded tirzepatide injection
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Direct Meds does not price
Visit RxSpan MD

Scores

Direct Meds 7.1 · RxSpan MD 7.9 out of 10. Six weighted parts.

Value25%

4.2A
vs
B
3.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

4.5A
vs
B
10.0

Accessibility10%

9.7A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

Direct Meds vs RxSpan MD: questions

Direct Meds has an open FDA warning letter dated September 9, 2025. RxSpan MD has none. Letters are matched to a seller by company, domain and address, never by a similar name.
RxSpan MD names four pharmacies. Direct Meds names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
RxSpan MD, by $576 a year at standing rates. Direct Meds: $297 a month, about $3,564 a year. RxSpan MD: $249 a month, about $2,988 a year.
Direct Meds has a minimum term (90-day supply shipped at once, remaining months billed every 30 days). RxSpan MD states you can cancel at any time.
Both Direct Meds and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Direct Meds 7.1, RxSpan MD 7.9).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks